אוגוסט, 2015 | Brintellix

Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

'מערכת אימד' 04/08/2015 14:48 סגור לתגובות

Abstract Vortioxetine is approved for the treatment of adults with major depressive disorder. This open-label extension (OLE) study evaluated the

קרא עוד ←

A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

'מערכת אימד' 01/08/2015 14:59 סגור לתגובות

Abstract This multicenter, randomized, double-blind, placebo-controlled, active-referenced (duloxetine 60 mg), parallel-group study evaluated the short-term efficacy and safety of vortioxetine (10–20 mg)

קרא עוד ←